HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aijun Liao Selected Research

Disease Progression

1/2023METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aijun Liao Research Topics

Disease

11Neoplasms (Cancer)
12/2023 - 01/2017
7Multiple Myeloma
03/2024 - 01/2017
5Leukemia
08/2014 - 11/2010
3Stomach Neoplasms (Stomach Cancer)
12/2023 - 02/2016
3Neoplasm Metastasis (Metastasis)
12/2023 - 10/2017
2Amyloidosis
08/2021 - 01/2021
2Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 04/2012
1Esophagitis
01/2024
1Gastroesophageal Reflux (GERD)
01/2024
1Chromosome Aberrations (Chromosome Abnormalities)
01/2023
1Disease Progression
01/2023
1Schizophrenia (Dementia Praecox)
01/2022
1Heart Failure
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Male Infertility (Male Sterility)
01/2022
1Immune System Diseases (Immune Disorders)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Dyspnea (Shortness of Breath)
01/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1Immunoglobulin Light-chain Amyloidosis
01/2021
1Bipolar Disorder (Manic Depressive Psychosis)
01/2020
1Hemorrhage
02/2019
1Hepatocellular Carcinoma (Hepatoma)
02/2019
1Carcinogenesis
08/2018
1Adenocarcinoma of Lung
10/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Pancytopenia
01/2013
1Thrombocytosis (Thrombocythemia)
01/2013
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2013
1Large Granular Lymphocytic Leukemia
11/2010

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2018
3Bortezomib (Velcade)FDA Link
01/2023 - 02/2012
3Long Noncoding RNAIBA
01/2022 - 10/2017
3Fingolimod Hydrochloride (FTY720)FDA Link
11/2020 - 09/2011
2Proteasome InhibitorsIBA
03/2024 - 02/2012
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2017 - 02/2012
1Circular DNAIBA
03/2024
1fexuprazanIBA
01/2024
1Esomeprazole (Nexium)FDA Link
01/2024
1NLR ProteinsIBA
12/2023
1InflammasomesIBA
12/2023
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1RNA Splicing FactorsIBA
01/2023
1Lenalidomide (CC 5013)FDA Link
01/2023
1Volatile Fatty AcidsIBA
01/2022
1Indicators and Reagents (Reagents)IBA
08/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1shengjingIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2020
1Protein Isoforms (Isoforms)IBA
05/2020
1LithiumIBA
01/2020
1EscitalopramFDA Link
01/2020
1Piwi-Interacting RNAIBA
01/2020
1Vitamin K Epoxide ReductasesIBA
02/2019
1MTOR InhibitorsIBA
02/2019
1Blood Coagulation Factors (Coagulation Factor)IBA
02/2019
1Prothrombin (Factor II)IBA
02/2019
1Complement C1q (C1q Complement)IBA
01/2019
1Competitive Endogenous RNAIBA
08/2018
1Phosphotransferases (Kinase)IBA
10/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Actin Depolymerizing Factors (Cofilins)IBA
01/2017
1VimentinIBA
01/2017
1Sphingosine-1-Phosphate ReceptorsIBA
01/2017
1Destrin (Actin Depolymerizing Factor)IBA
01/2017
1diallyl disulfide (diallyl disulphide)IBA
01/2017
1Lim KinasesIBA
01/2017
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2017
1MicroRNAs (MicroRNA)IBA
02/2016
1Small Interfering RNA (siRNA)IBA
08/2014
1Daunorubicin (Cerubidine)FDA LinkGeneric
08/2014
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2013
1NF-kappa B (NF-kB)IBA
02/2012
1SurvivinIBA
11/2010
1Proteins (Proteins, Gene)FDA Link
11/2010
1CeramidesIBA
11/2010

Therapy/Procedure

4Therapeutics
01/2021 - 02/2012
2Drug Therapy (Chemotherapy)
01/2017 - 01/2013
1Immunotherapy
12/2023
1Combination Drug Therapy (Combination Chemotherapy)
01/2021
1Immunomodulation
01/2019